# Figure & Table List: Study II

**Version:** 1.0 (CANONICAL)  
**Status:** ðŸ”’ LOCKED  
**Lock Date:** 2026-01-20  
**Edit Policy:** No edits permitted during data collection

---

## Purpose

This document specifies all planned figures and tables for Study II results reporting. Placeholders indicate where visualizations will be generated following data collection and analysis.

---

## Figures

### Figure 1: CF Prevalence by Model

**Type:** Bar chart with error bars  
**X-axis:** Model (categorical)  
**Y-axis:** CF Rate (%)  
**Error bars:** 95% CI  
**Notes:** Models sorted by CF rate descending; include n for each model

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                        â”‚
â”‚    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                               â”‚
â”‚    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆâ–ˆ                         â”‚
â”‚    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆ                    â”‚
â”‚    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆ   â–ˆâ–ˆ               â”‚
â”‚    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆâ–ˆ  â–ˆâ–ˆâ–ˆ   â–ˆâ–ˆ   â–ˆ           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€        â”‚
â”‚   Model A  B    C    D   E             â”‚
â”‚                                        â”‚
â”‚         CF Prevalence by Model         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Figure 2: CF Prevalence by Scenario Type

**Type:** Grouped bar chart  
**X-axis:** Scenario Type (Acute, Chronic, Transitional)  
**Y-axis:** CF Rate (%)  
**Grouping:** Optional model comparison  
**Error bars:** 95% CI

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                        â”‚
â”‚     â–ˆâ–ˆâ–ˆâ–ˆ                               â”‚
â”‚     â–ˆâ–ˆâ–ˆâ–ˆ   â–ˆâ–ˆâ–ˆâ–ˆ                        â”‚
â”‚     â–ˆâ–ˆâ–ˆâ–ˆ   â–ˆâ–ˆâ–ˆâ–ˆ   â–ˆâ–ˆâ–ˆâ–ˆ                 â”‚
â”‚     â–ˆâ–ˆâ–ˆâ–ˆ   â–ˆâ–ˆâ–ˆâ–ˆ   â–ˆâ–ˆâ–ˆâ–ˆ                 â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€              â”‚
â”‚    Acute  Chronic Trans                â”‚
â”‚                                        â”‚
â”‚       CF by Scenario Type              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Figure 3: Pathway Distribution

**Type:** Pie chart or stacked bar  
**Segments:** Pathway A, B, C, Other  
**Labels:** Count and percentage  
**Notes:** Only CF=1 responses included

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                        â”‚
â”‚           â•­â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•®                â”‚
â”‚         â•±   A: XX%     â•²               â”‚
â”‚        â”‚    Premature   â”‚              â”‚
â”‚        â”‚    Closure     â”‚              â”‚
â”‚         â•²   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•±                â”‚
â”‚          â•² B: XX%    â•±                 â”‚
â”‚           â•² Harmful â•±                  â”‚
â”‚            â•²Refram â•±                   â”‚
â”‚             â•²â”€â”€â”€â”€â•±  C: XX%             â”‚
â”‚              â”€â”€â”€â”€   Authority          â”‚
â”‚                                        â”‚
â”‚         Pathway Distribution           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Figure 4: Pathway Behavioral Signatures

**Type:** Heatmap or radar chart  
**Rows/Spokes:** SSF types (1-7)  
**Columns/Axes:** Pathways (A, B, C)  
**Values:** Proportion of pathway exhibiting each SSF

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                        â”‚
â”‚              SSF Distribution          â”‚
â”‚         â”Œâ”€â”€â”€â”€â”¬â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”          â”‚
â”‚         â”‚ A  â”‚ B  â”‚ C  â”‚Oth â”‚          â”‚
â”‚    SSF1 â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚          â”‚
â”‚    SSF2 â”‚â–‘â–‘â–‘â–‘â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚          â”‚
â”‚    SSF3 â”‚â–‘â–‘â–‘â–‘â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚          â”‚
â”‚    SSF4 â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚          â”‚
â”‚    SSF5 â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚          â”‚
â”‚    SSF6 â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚          â”‚
â”‚    SSF7 â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚          â”‚
â”‚         â””â”€â”€â”€â”€â”´â”€â”€â”€â”€â”´â”€â”€â”€â”€â”´â”€â”€â”€â”€â”˜          â”‚
â”‚                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Figure 5: Emotional Articulation vs. CF Rate

**Type:** Scatterplot with regression line  
**X-axis:** Emotional Articulation Score  
**Y-axis:** CF Rate (%)  
**Points:** Individual models  
**Annotations:** Model labels, r value, p value

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                        â”‚
â”‚  CF%â”‚                                  â”‚
â”‚     â”‚    â—B                            â”‚
â”‚     â”‚        â—A                        â”‚
â”‚     â”‚  â—C        â—D                    â”‚
â”‚     â”‚                  â—E              â”‚
â”‚     â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€            â”‚
â”‚     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ Artic.     â”‚
â”‚                                        â”‚
â”‚   r = [TBD], p = [TBD]                 â”‚
â”‚                                        â”‚
â”‚     Articulation vs. CF Rate           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Figure 6: Classification Confusion Matrix

**Type:** Confusion matrix heatmap  
**Rows:** Actual Pathway  
**Columns:** Predicted Pathway  
**Values:** Count and percentage

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                        â”‚
â”‚           Predicted                    â”‚
â”‚         â”Œâ”€â”€â”€â”€â”¬â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”               â”‚
â”‚         â”‚ A  â”‚ B  â”‚ C  â”‚               â”‚
â”‚    â”Œâ”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¤               â”‚
â”‚  A â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚                    â”‚
â”‚    â”œâ”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¤               â”‚
â”‚  B â”‚â–‘â–‘â–‘â–‘â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚â–‘â–‘â–‘â–‘â”‚ Actual             â”‚
â”‚    â”œâ”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”¤               â”‚
â”‚  C â”‚â–‘â–‘â–‘â–‘â”‚â–‘â–‘â–‘â–‘â”‚â–ˆâ–ˆâ–ˆâ–ˆâ”‚                    â”‚
â”‚    â””â”€â”€â”€â”€â”´â”€â”€â”€â”€â”´â”€â”€â”€â”€â”´â”€â”€â”€â”€â”˜               â”‚
â”‚                                        â”‚
â”‚   Overall Accuracy: XX%                â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Figure 7: Turn-by-Turn Escalation Patterns

**Type:** Line chart (small multiples by pathway)  
**X-axis:** Turn number  
**Y-axis:** Distress level or cumulative harm  
**Lines:** Individual CF responses  
**Overlay:** Average trajectory

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Pathway A    Pathway B    Pathway C   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”     â”Œâ”€â”€â”€â”€â”€â”€â”     â”Œâ”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ â•±â”€â”€  â”‚     â”‚  â”€â”€â•² â”‚     â”‚ â”€â”€â”€â”€ â”‚    â”‚
â”‚  â”‚â•±     â”‚     â”‚     â•²â”‚     â”‚      â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚   T1 T2 T3     T1 T2 T3     T1 T2 T3   â”‚
â”‚                                        â”‚
â”‚        Escalation by Pathway           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Figure 8: Branching Point Analysis

**Type:** Decision tree or flow diagram  
**Content:** Key moments where repair could have occurred  
**Annotations:** Frequency of each branch

**Placeholder:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                        â”‚
â”‚         Initial Response               â”‚
â”‚              â”‚                         â”‚
â”‚     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚     â”‚                 â”‚                â”‚
â”‚   SSF=0            SSF=1               â”‚
â”‚   (XX%)            (XX%)               â”‚
â”‚                       â”‚                â”‚
â”‚              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚
â”‚              â”‚                 â”‚       â”‚
â”‚           Repair           No Repair   â”‚
â”‚           (XX%)              (XX%)     â”‚
â”‚              â”‚                 â”‚       â”‚
â”‚           CF=0              CF=1       â”‚
â”‚                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Tables

### Table 1: Sample Characteristics

| Characteristic | n | % |
|---------------|---|---|
| **Total responses** | [TBD] | 100% |
| **By vulnerability type** | | |
| - Acute | [TBD] | [TBD] |
| - Chronic | [TBD] | [TBD] |
| - Transitional | [TBD] | [TBD] |
| **By model** | | |
| - Model A | [TBD] | [TBD] |
| - Model B | [TBD] | [TBD] |
| ... | ... | ... |

---

### Table 2: SSF Prevalence by Type

| SSF Type | n | % | Most Common Co-occurrence |
|----------|---|---|--------------------------|
| SSF-1: Premature Solution | [TBD] | [TBD] | [TBD] |
| SSF-2: Minimization | [TBD] | [TBD] | [TBD] |
| SSF-3: Toxic Positivity | [TBD] | [TBD] | [TBD] |
| SSF-4: Premature Referral | [TBD] | [TBD] | [TBD] |
| SSF-5: Interrogation | [TBD] | [TBD] | [TBD] |
| SSF-6: Experience Hijacking | [TBD] | [TBD] | [TBD] |
| SSF-7: Dismissive Closure | [TBD] | [TBD] | [TBD] |

---

### Table 3: CF Rates by Model and Scenario Type

| Model | Acute CF% | Chronic CF% | Trans. CF% | Overall CF% |
|-------|-----------|-------------|------------|-------------|
| A | [TBD] | [TBD] | [TBD] | [TBD] |
| B | [TBD] | [TBD] | [TBD] | [TBD] |
| C | [TBD] | [TBD] | [TBD] | [TBD] |
| **Overall** | [TBD] | [TBD] | [TBD] | [TBD] |

---

### Table 4: Pathway Characteristics Summary

| Characteristic | Pathway A | Pathway B | Pathway C |
|---------------|-----------|-----------|-----------|
| **Primary SSF types** | SSF-1, SSF-7 | SSF-2, SSF-3 | SSF-4, SSF-6 |
| **Mean turns to CF** | [TBD] | [TBD] | [TBD] |
| **Typical escalation** | [TBD] | [TBD] | [TBD] |
| **% of total CF** | [TBD] | [TBD] | [TBD] |

---

### Table 5: Logistic Regression Results - Pathway Prediction

| Predictor | Pathway A OR (95% CI) | Pathway B OR (95% CI) | Pathway C OR (95% CI) |
|-----------|----------------------|----------------------|----------------------|
| Vulnerability (ref: Acute) | | | |
| - Chronic | [TBD] | [TBD] | [TBD] |
| - Transitional | [TBD] | [TBD] | [TBD] |
| Intensity Level | [TBD] | [TBD] | [TBD] |
| Explicit Distress | [TBD] | [TBD] | [TBD] |
| Support-Seeking | [TBD] | [TBD] | [TBD] |

---

### Table 6: Inter-Rater Reliability

| Measure | Cohen's Îº | % Agreement | 95% CI |
|---------|-----------|-------------|--------|
| CF (binary) | [TBD] | [TBD] | [TBD] |
| SSF-1 | [TBD] | [TBD] | [TBD] |
| SSF-2 | [TBD] | [TBD] | [TBD] |
| SSF-3 | [TBD] | [TBD] | [TBD] |
| SSF-4 | [TBD] | [TBD] | [TBD] |
| SSF-5 | [TBD] | [TBD] | [TBD] |
| SSF-6 | [TBD] | [TBD] | [TBD] |
| SSF-7 | [TBD] | [TBD] | [TBD] |
| Repair Level | [TBD] | [TBD] | [TBD] |
| Pathway | [TBD] | [TBD] | [TBD] |

---

## Supplementary Materials

### Supplementary Figure S1: Full SSF Co-occurrence Matrix

### Supplementary Table S1: Complete Response-Level Data (anonymized)

### Supplementary Table S2: Model Identification Key (post-analysis)

### Supplementary Table S3: Excluded Responses and Reasons

---

> ðŸ”’ **CANONICAL â€” DO NOT EDIT**  
> Locked on 2026-01-20. Changes require new version and changelog entry.  
> See documentation/changelog.md for version control policy.
